226 related articles for article (PubMed ID: 23672202)
1. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
Kuramoto T; Umegaki E; Nouda S; Narabayashi K; Kojima Y; Yoda Y; Ishida K; Kawakami K; Abe Y; Takeuchi T; Inoue T; Murano M; Tokioka S; Higuchi K
BMC Gastroenterol; 2013 May; 13():85. PubMed ID: 23672202
[TBL] [Abstract][Full Text] [Related]
2. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
Umegaki E; Kuramoto T; Kojima Y; Nouda S; Ishida K; Takeuchi T; Inoue T; Tokioka S; Higuchi K
Intern Med; 2014; 53(4):283-90. PubMed ID: 24531083
[TBL] [Abstract][Full Text] [Related]
3. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs.
Isomura Y; Yamaji Y; Yamada A; Watanabe Y; Suzuki H; Kobayashi Y; Yoshida S; Watabe H; Hirata Y; Yoshida H; Koike K
Gastrointest Endosc; 2014 Jul; 80(1):118-25. PubMed ID: 24518124
[TBL] [Abstract][Full Text] [Related]
4. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
Fujimori S; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Gastrointest Endosc; 2009 Jun; 69(7):1339-46. PubMed ID: 19243767
[TBL] [Abstract][Full Text] [Related]
5. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
[TBL] [Abstract][Full Text] [Related]
7. Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.
Huang C; Lu B; Fan YH; Zhang L; Jiang N; Zhang S; Meng LN
World J Gastroenterol; 2014 Aug; 20(31):11012-8. PubMed ID: 25152605
[TBL] [Abstract][Full Text] [Related]
8. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
Maiden L; Thjodleifsson B; Theodors A; Gonzalez J; Bjarnason I
Gastroenterology; 2005 May; 128(5):1172-8. PubMed ID: 15887101
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs.
Massimo Claar G; Monaco S; Del Veccho Blanco C; Capurso L; Fusillo M; Annibale B
Aliment Pharmacol Ther; 1998 May; 12(5):463-8. PubMed ID: 9663727
[TBL] [Abstract][Full Text] [Related]
13. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.
Scarpignato C; Dolak W; Lanas A; Matzneller P; Renzulli C; Grimaldi M; Zeitlinger M; Bjarnason I
Gastroenterology; 2017 Apr; 152(5):980-982.e3. PubMed ID: 28007576
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study.
Niwa Y; Nakamura M; Miyahara R; Ohmiya N; Watanabe O; Ando T; Kawashima H; Itoh A; Hirooka Y; Goto H
Digestion; 2009; 80(4):260-6. PubMed ID: 19844108
[TBL] [Abstract][Full Text] [Related]
16. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
17. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
19. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
Lad R; Armstrong D
Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury.
Zhang S; Chao GQ; Lu B
Rheumatol Int; 2013 Oct; 33(10):2513-21. PubMed ID: 23604681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
